Boiron USA (BOI) Stock Price & News

Why is BOI down 2,12%?

Dive Deeper

BOI:EPA

Boiron USA

18,50 €

-2,12%

(-0,40) 1D

28 հոկ, 17:35:04 GMT+1 · EUR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for BOI...

Open

19,00 €

High

19,00 €

Low

18,20 €

Mkt. cap

356,67 մլն

Avg. vol.

6,85 հզր

Volume

4,65 հզր

P/E ratio

12,26

52-wk high

32,25 €

52-wk low

16,90 €

EPS

1,51 €

Shares outstanding

17,55 մլն

No. of employees

3 հզր

Open

19,00 €

High

19,00 €

Low

18,20 €

Mkt. cap

356,67 մլն

Avg. vol.

6,85 հզր

Volume

4,65 հզր

P/E ratio

12,26

52-wk high

32,25 €

52-wk low

16,90 €

EPS

1,51 €

Shares outstanding

17,55 մլն

No. of employees

3 հզր

Related stocks

Compagnie des Alpes SA

News stories

From web sources and news partners

www.marketscreener.com

18 րոպե առաջ

Four companies on Nasdaq Stockholm trade ex-dividend today

Financial Times

41 րոպե առաջ

US tech stocks set to fall after earnings fuel AI spending concerns

BigGo Finance

56 րոպե առաջ

General Motors Bids Farewell to 115-Year-Old Home, Moves to Nasdaq on Nov. 17 to Chase Tech-Stock Glow

Reuters

3 ժամ առաջ

Asian shares fall as Alphabet earnings miss drags Wall St futures lower

Profile

Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index. In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations. Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs". Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia

About Boiron USA

CEO-

Employees2,62 հզր

Founded07 հնս, 1932 թ.

Headquarters-

Sector-

Websiteboiron.fr

All values in EUR	2025 թ. սեպ	2025 թ. դեկ	2026 թ. մրտ	2026 թ. հնս
Revenue	127,73 մլն	127,73 մլն	120,16 մլն	120,16 մլն
Cost of goods sold	35,40 մլն	35,40 մլն	33,53 մլն	33,53 մլն
Cost of revenue	35,40 մլն	35,40 մլն	33,53 մլն	33,53 մլն
Research and development expenses	1,56 մլն	1,56 մլն	1,44 մլն	1,44 մլն
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	79,26 մլն	79,26 մլն	79,95 մլն	79,95 մլն
Operating expense	77,52 մլն	77,52 մլն	81,88 մլն	81,88 մլն
Total operating expenses	112,92 մլն	112,92 մլն	115,41 մլն	115,41 մլն
Operating income	14,81 մլն	14,81 մլն	4,76 մլն	4,76 մլն
Other non operating income	-1,13 մլն	-1,13 մլն	-2,29 մլն	-2,29 մլն
EBT including unusual items	13,82 մլն	13,82 մլն	4,02 մլն	4,02 մլն
EBT excluding unusual items	13,16 մլն	13,16 մլն	2,75 մլն	2,75 մլն
Income tax expense	3,18 մլն	3,18 մլն	1,56 մլն	1,56 մլն
Effective tax rate	22,99%	22,99%	38,90%	38,90%
Other operating expenses	-3,30 մլն	-3,30 մլն	488,00 հզր	488,00 հզր
Net income	10,64 մլն	10,64 մլն	2,46 մլն	2,46 մլն
Net profit margin	8,33%	8,33%	2,04%	2,04%
Earnings per share	-	-	-	-
Interest and investment income	653,00 հզր	653,00 հզր	636,50 հզր	636,50 հզր
Interest expense	-335,00 հզր	-335,00 հզր	-410,00 հզր	-410,00 հզր
Net interest expenses	318,00 հզր	318,00 հզր	226,50 հզր	226,50 հզր
Depreciation and amortization charges	-	-	-	-
EBITDA	18,06 մլն	18,06 մլն	11,17 մլն	11,17 մլն
Gain or loss from assets sale	-446,00 հզր	-446,00 հզր	-	-

Ask anything